These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23808828)

  • 1. Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.
    Zhu R; Wu X; Xiao Y; Gao B; Xie Q; Liu H; Wang S
    Cancer Biother Radiopharm; 2013 Oct; 28(8):579-87. PubMed ID: 23808828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment.
    Kim TH; Lee GJ; Kang JH; Kim HJ; Kim TI; Oh JM
    Biomed Res Int; 2014; 2014():193401. PubMed ID: 24860812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
    Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
    Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS; Cho CW
    Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.
    Khallaf RA; Salem HF; Abdelbary A
    Drug Deliv; 2016 Nov; 23(9):3452-3460. PubMed ID: 27240935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Int J Pharm; 2010 Oct; 398(1-2):190-203. PubMed ID: 20655375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma.
    Li H; Tian J; Wu A; Wang J; Ge C; Sun Z
    Int J Nanomedicine; 2016; 11():4373-80. PubMed ID: 27621628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
    Ni W; Li Z; Liu Z; Ji Y; Wu L; Sun S; Jian X; Gao X
    J Pharm Sci; 2019 Mar; 108(3):1284-1295. PubMed ID: 30395829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
    Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma.
    Masloub SM; Elmalahy MH; Sabry D; Mohamed WS; Ahmed SH
    Arch Oral Biol; 2016 Apr; 64():1-10. PubMed ID: 26735343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green encapsulation of LDH(Zn/Al)-5-Fu with carboxymethyl cellulose biopolymer; new nanovehicle for oral colorectal cancer treatment.
    Pooresmaeil M; Behzadi Nia S; Namazi H
    Int J Biol Macromol; 2019 Oct; 139():994-1001. PubMed ID: 31401278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.